JT
Jalinder Tatyasaheb Pol
About Jalinder Tatyasaheb Pol
Data last updated:
Jalinder Tatyasaheb Pol is a Director at Brewster Pharma Private Limited (since 2018), Director at Nikop Hospital Pvt Ltd (since 1989) and Partner at Elysia Heart Institute Llp (since 2024), and holds 1 more current directorship. The companies operate in Business Services and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹2.35 Cr; the largest is Brewster Pharma Private Limited at ₹2.32 Cr (FY 2025). Earlier, Jalinder Tatyasaheb Pol was a Director at Baramati Mri & Diagnostics & Research Center Private Limited (2010–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brewster Pharma Private Limited U74999MH2017PTC402264 | Director | 18 Sep 2018 | 2017 | ₹2.32 Cr (FY 2025) | Active |
| Nikop Hospital Pvt Ltd U85110PN1989PTC050544 | Director | 02 Feb 1989 | 1989 | ₹3 Lakh (FY 2025) | Active |
| Elysia Heart Institute Llp ACK-9371 | Partner | 19 Dec 2024 | 2024 | Active | |
| Sona Nikop Heart Care Centre Llp AAE-5561 | Designated Partner | 12 Aug 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Baramati Mri & Diagnostics & Research Center Private Limited U85100PN2010PTC136877 | Director | 19 Jul 2010 | 2010 | ₹21,151 (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jalinder Tatyasaheb Pol
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jalinder Tatyasaheb Pol
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jalinder Tatyasaheb Pol
Jalinder Tatyasaheb Pol currently holds 4 directorships: Brewster Pharma Private Limited (Director, since 18 Sep 2018, revenue ₹2.32 Cr (FY 2025)); Nikop Hospital Pvt Ltd (Director, since 02 Feb 1989, revenue ₹3 Lakh (FY 2025)); Elysia Heart Institute Llp (Partner, since 19 Dec 2024); Sona Nikop Heart Care Centre Llp (Designated Partner, since 12 Aug 2015).
Jalinder Tatyasaheb Pol was first appointed on 02 Feb 1989 as Director at Nikop Hospital Pvt Ltd. The most recent appointment on record is 19 Dec 2024 at Elysia Heart Institute Llp.
The 2 current companies of Jalinder Tatyasaheb Pol that report revenue have a combined latest revenue of ₹2.35 Cr: Brewster Pharma Private Limited ₹2.32 Cr (FY 2025); Nikop Hospital Pvt Ltd ₹3 Lakh (FY 2025).
Jalinder Tatyasaheb Pol held 1 earlier board appointment: Baramati Mri & Diagnostics & Research Center Private Limited (Director, 19 Jul 2010 to 04 May 2019).
The current boards of Jalinder Tatyasaheb Pol's companies include Abhijit Adsul Dnyanoba (Brewster Pharma Private Limited), Amit Arun Patil (Brewster Pharma Private Limited), Hemant Vitthal Patil (Brewster Pharma Private Limited), Kirankumar Dnyandeo Nale (Brewster Pharma Private Limited), Krishna Ramrao Galinde (Brewster Pharma Private Limited), Kunal Ramdas Ghone (Brewster Pharma Private Limited), among others.